Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.085 CAD | 0.00% | 0.00% | +30.77% |
Business Summary
Number of employees: 166
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canadian Adult Use and Wellness
31.0
%
| 13 | 60.2 % | 10 | 31.0 % | -22.96% |
Canadian Medical Cannabis - Other
29.9
%
| - | - | 10 | 29.9 % | - |
International Medical Cannabis
29.2
%
| 5 | 22.9 % | 10 | 29.2 % | +90.34% |
Canadian Medical Cannabis - Clinics
5.6
%
| - | - | 2 | 5.6 % | - |
Pharmaceutical and Business to Business
4.2
%
| 4 | 16.8 % | 1 | 4.2 % | -62.52% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
69.8
%
| 15 | 66.4 % | 23 | 69.8 % | +57.17% |
Australia
16.3
%
| 3 | 11.8 % | 5 | 16.3 % | +106.63% |
Germany
10.8
%
| 4 | 16.5 % | 4 | 10.8 % | -1.89% |
Other
3.0
%
| 1 | 5.3 % | 1 | 3.0 % | -14.02% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Pidduck
CEO | Chief Executive Officer | - | 22-04-19 |
Greg Hunter
DFI | Director of Finance/CFO | - | 21-02-07 |
Keith Strachan
PSD | President | - | 18-09-30 |
William Gordon
CTO | Chief Tech/Sci/R&D Officer | - | 16-10-31 |
Kirk Binns
AUD | Comptroller/Controller/Auditor | - | 19-02-05 |
Ahmed Shehata
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Bumby
BRD | Director/Board Member | 60 | 23-03-31 |
David Pidduck
CEO | Chief Executive Officer | - | 22-04-19 |
Shelley Martin
BRD | Director/Board Member | - | 20-06-21 |
Chris Halyk
BRD | Director/Board Member | - | 20-08-03 |
Keith Strachan
PSD | President | - | 18-09-30 |
Chris Taves
CHM | Chairman | - | 20-07-12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 404,233,466 | 394,237,299 ( 97.53 %) | 0 | 97.53 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.46% | 25.17M | |
+44.36% | 6.34B | |
-13.52% | 4.61B | |
+10.85% | 3.39B | |
-6.52% | 3.29B | |
+51.14% | 2.02B | |
-5.22% | 1.73B | |
+1.29% | 1.67B | |
+57.69% | 1.63B | |
-9.67% | 1.59B |
- Stock Market
- Equities
- LABS Stock
- Company MediPharm Labs Corp.